Bristol-Myers Squibb Company
NYSE: BMY
$55.83
-$0.98 (-1.7%)
Closing Price on January 10, 2025
BMY Articles
October 7, 2016: Here are four stocks trading with relatively heavy volume among 26 equities making new 52-week lows in Monday’s session. On the NYSE, advancers led decliners by about 2.5 to 1 and...
Published:
Last Updated:
On Monday morning, Merck, Mylan and Bristol-Myers Squibb made substantial runs, either up or down.
Published:
Last Updated:
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. October 3, 2016: Here are four stocks trading with...
Published:
Last Updated:
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. September 28, 2016: Here are four stocks trading with...
Published:
Last Updated:
The September 15 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks, short interest has increased.
Published:
Last Updated:
Despite recent market headwinds and volatility, there are strong underlying fundamentals among the large cap pharmaceuticals that are continuing to drive them forward.
Published:
Last Updated:
The August 31 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks, short interest has significantly decreased.
Published:
Last Updated:
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. September 12, 2016: Here are four stocks trading with...
Published:
Last Updated:
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. September 2, 2016: Here are four stocks trading with...
Published:
Last Updated:
The August 15 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks, short interest has significantly decreased.
Published:
Last Updated:
The July 29 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks, short interest was lower.
Published:
Last Updated:
Credit Suisse sees the Bristol-Myers Squibb gap with Merck getting even worse, even though it still has robust I-O franchise estimates for Bristol-Myers.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Monday morning include BlackRock, Bristol-Myers, Level 3, NVIDIA, Monsanto and Twenty-First Century Fox.
Published:
Last Updated:
Bristol-Myers Squibb shares took a nosedive early Friday's following an update in its late-stage Checkmate trial. But Bristol-Myer's failure was a big win for Merck.
Published:
Last Updated:
Bristol-Myers Squibb released a better-than-expected second-quarter earnings report before the markets opened on Thursday.
Published:
Last Updated:
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.